Evidence map›Paper›PMID 21228350›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge.

Jeroen E J Guikema, Rachel M Gerstein, Erin K Linehan, Erin K Cloherty, Eric Evan-Browning, Daisuke Tsuchimoto, Yusaku Nakabeppu, Carol E Schrader

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. APE2 Zf-GRF facilitates 3'-5' resection of DNA damage following oxidative stress.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Base excision repair and cancer.Cancer letters · 2012
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jeroen E J GuikemaDepartment of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Rachel M Gerstein
Erin K Linehan
Erin K Cloherty
Eric Evan-Browning
Daisuke Tsuchimoto
Yusaku Nakabeppu
Carol E Schrader
University of Massachusetts Chan Medical School · USKyushu University · JP

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
REGULATION OF V(D)J RECOMBINATION IN B CELL DEVELOPMENTR01AI043534 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GERSTEIN, RACHEL M. · 2000 to 2011
$3.1M
DNA Breaks in Class Switch RecombinationR01AI065639 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHRADER, CAROL E · 2005 to 2009
$1.3M
NIAID NIH HHS R01 AI043534NIAID NIH HHS R01 AI065639NIDDK NIH HHS 5 P30 DK32520NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

B cell development involves rapid cellular proliferation, gene rearrangements, selection, and differentiation, and it provides a powerful model to study DNA repair processes in vivo. Analysis of the contribution of the base excision repair pathway in lymphocyte development has been lacking primarily owing to the essential nature of this repair pathway. However, mice deficient for the base excision repair enzyme, apurinic/apyrimidinic endonuclease 2 (APE2) protein develop relatively normally, but they display defects in lymphopoiesis. In this study, we present an extensive analysis of bone marrow hematopoiesis in mice nullizygous for APE2 and find an inhibition of the pro-B to pre-B cell transition. We find that APE2 is not required for V(D)J recombination and that the turnover rate of APE2-deficient progenitor B cells is nearly normal. However, the production rate of pro- and pre-B cells is reduced due to a p53-dependent DNA damage response. FACS-purified progenitors from APE2-deficient mice differentiate normally in response to IL-7 in in vitro stromal cell cocultures, but pro-B cells show defective expansion. Interestingly, APE2-deficient mice show a delay in recovery of B lymphocyte progenitors following bone marrow depletion by 5-fluorouracil, with the pro-B and pre-B cell pools still markedly decreased 2 wk after a single treatment. Our data demonstrate that APE2 has an important role in providing protection from DNA damage during lymphoid development, which is independent from its ubiquitous and essential homolog APE1.

Indexed as

AnimalsB-Lymphocyte SubsetsCells, CulturedCoculture TechniquesDNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA RepairEndonucleasesFluorouracilHematopoietic Stem CellsLymphocyte DepletionLymphocyte SubsetsLymphopoiesisMiceMice, KnockoutMultifunctional EnzymesApex1 protein, mouseApex2 protein, mouseDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesFluorouracilMultifunctional EnzymesTumor Suppressor Protein p53

Identifiers

PMID21228350
PMCPMC4041036
OpenAlexW2172081203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.